This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: Cherie A Lipowsky: Innovator in Natriuretic Peptide Research
Introduction
Cherie A Lipowsky is a notable inventor based in Roselle, IL (US). She has made significant contributions to the field of biochemistry, particularly in the study of human natriuretic peptides. With a total of 2 patents, her work has advanced the understanding and measurement of these important biomarkers.
Latest Patents
Cherie A Lipowsky's latest patents include a method of stabilizing human natriuretic peptides. This invention relates to methods for making stable test samples that can be used in ligand-binding assays for measuring natriuretic peptides. Another significant patent is for stable compositions for measuring human natriuretic peptides, which also pertains to methods for creating stable compositions that can be utilized in ligand-binding assays.
Career Highlights
Cherie is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on innovative solutions that enhance the reliability of peptide measurements in clinical settings.
Collaborations
Throughout her career, Cherie has collaborated with esteemed colleagues such as Ray A Weigand and Judith A Friese. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Cherie A Lipowsky's contributions to the field of natriuretic peptide research exemplify her dedication to advancing medical science. Her patents and work at Abbott Laboratories Corporation highlight her role as a key innovator in this important area of study.